Publication:
Serum obestatin and omentin levels in patients with diabetic nephropathy

Simple item page
dc.contributor.authorZORLU, MEHMET
dc.contributor.authorKISKAC, MUHARREM
dc.contributor.authorGueler, ERAY METİN
dc.contributor.authorGUELTEPE, I.
dc.contributor.authorYAVUZ, E.
dc.contributor.authorCELIK, K.
dc.contributor.authorKOCYIGIT, ABDÜRRAHİM
dc.contributor.institutionauthorZORLU, MEHMET
dc.contributor.institutionauthorKISKAÇ, MUHARREM
dc.contributor.institutionauthorGÜLER, ERAY METİN
dc.contributor.institutionauthorKOÇYİĞİT, ABDÜRRAHİM
dc.date.accessioned2019-10-05T12:36:52Z
dc.date.available2019-10-05T12:36:52Z
dc.date.issued2017-02-01
dc.description.abstractIntroduction: Diabetic nephropathy is the leading cause of chronic kidney disease and accounts for almost 45% of all new patients requiring renal replacement therapy. Omentin and obestatin, two novel proteins were suggested to be associated with insulin resistance, type 2 diabetes and cardiovascular risk factors. Thus, we postulated that they may also have an association with diabetic nephropathy which is known to be an independent cardiovascular risk factor. In order to investigate such an association we compared serum omentin and obestatin levels in type 2 diabetic patients with normoalbuminuria (NA) and macroalbuminuria (MA). Materials and Methods: A total of 81 type 2 diabetic patients were separated into two groups according to their proteinuria status; patients with NA (n = 39) and patients with MA (n = 42). Two groups were compared in terms of serum omentin and obestatin levels. Results: While serum omentin levels did not differ among two groups (P = 0.407), serum obestatin levels were significantly higher in MA group (P = 0.001). Conclusion: The results of this study showed that higher serum levels of obestatin were associated with macro albuminuria suggesting that obestatin may have a role in underlying pathogenic mechanisms that leads to diabetic nephropathyen
dc.identifier10.5455/apd.201002
dc.identifier.citationZORLU M., KISKAC M., Gueler E. M. , GUELTEPE I., YAVUZ E., CELIK K., KOCYIGIT A., -Serum obestatin and omentin levels in patients with diabetic nephropathy-, NIGERIAN JOURNAL OF CLINICAL PRACTICE, cilt.20, ss.182-187, 2017
dc.identifier.pubmed28091434
dc.identifier.urihttps://hdl.handle.net/20.500.12645/168
dc.language.isotr
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectDiabetes mellitus type 2
dc.subjectDiabetic nephropathy
dc.subjectObestatin
dc.subjectOmentin
dc.titleSerum obestatin and omentin levels in patients with diabetic nephropathy
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameAnadolu Psikiyatri Dergisi
local.avesis.id00c66591-cf47-4d62-94e9-943d418ace9b
local.avesis.response
local.org.facultyTıp Fakültesi
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
relation.isAuthorOfPublication72084e17-e46e-438f-925e-0a24ad5f9850
relation.isAuthorOfPublication777d95d8-6fb6-4952-80c1-727755625e7e
relation.isAuthorOfPublication68927a51-77a5-4d08-8370-23b470160061
relation.isAuthorOfPublication75babbd2-f46b-4121-aa00-54d883a6f907
relation.isAuthorOfPublication.latestForDiscovery72084e17-e46e-438f-925e-0a24ad5f9850
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
52-10.4103-1119-3077.181350.pdf
Size:
537.82 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Yayınlar - Eserler
Tıp Fakültesi